A. Menarini Industrie Farmaceutiche Riunite s.r.l. has 38 disclosed EU lobbying meetings from 2025-03-18 to 2026-06-03: 5 with the European Commission and 33 with Members of the European Parliament. Source: EU Transparency Register no. 138719717404-80, Commission disclosures and MEP declarations. Methodology
A. Menarini Industrie Farmaceutiche Riunite s.r.l.
EU lobbying footprint — who they meet, and on what.
- Register no.
- 138719717404-80 ↗
- Disclosed meetings
- 38 (5 Commission · 33 MEP)
- Period
- 2025-03-18 → 2026-06-03
Declared fields of interest: Budget · Business and industry · Communication · Competition · Digital economy and society · Economy, finance and the euro · Education and training · Employment and social affairs · Energy · Environment · European neighbourhood policy · External relations
Lobbying profile
as declared 2026-03-04- Category
- Companies & groups
- Legal status
- S.R.L.
- Declared lobbying cost
- €100,000
- Lobbying FTEs
- 2.25
- Members
- 3
At a glance
- Health3
- Technology2
- Olivér Várhelyi2
- Maurice Whelan1
- Tobias Wiesenthal1
- Giulia Del Brenna1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- UWWTDsource ↗
- Environmentsource ↗
- 2026-05-28ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiChallenges and priorities for health and life sciencessource ↗
- 2026-05-28ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiEU initiatives in the field of pharmaceutical sectorsource ↗
- Biotech Actsource ↗
- Biotech Actsource ↗
- ENVIsource ↗
- Health Policysource ↗
- Critical medicines actsource ↗
- ITRE committeesource ↗
- UWWTDsource ↗
- Urban Waste Water Directive and EPRsource ↗
- UWWTD RESOLUTIONsource ↗
- EU Biotech Act Isource ↗
- SANT COMMITTEE ONGOING WORKsource ↗
- Introductory meetingsource ↗
- MFFsource ↗
- Europe de la santésource ↗
- Critical medicines actsource ↗
- medicinessource ↗
- Biotechnology, Critical medicines, pharmaceutical policysource ↗
- EU Policy Tools to Safeguard Access to Critical Medicinessource ↗
- Cardiovascular diseases, oncology, pain/inflammation, asthmasource ↗
- Critical Medicines Actsource ↗
- Critical Medicine Actsource ↗
- Critical Medicines Actsource ↗
- Critical Medicines Actsource ↗
- Critical Medicines Act (follow up)source ↗
- Critical Medicinessource ↗
- Pharmaceuticalssource ↗
- Incontro conoscitivosource ↗
- Health policysource ↗
- Critical medicines actsource ↗
- Healthsource ↗
- 2025-04-04ECMaurice Whelan · Head of UnitScientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- 2025-04-04ECTobias Wiesenthal · Head of UnitScientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- Discussion on the Critical Medicines Act and its role in improving medicine availability and supporting EU-based manufacturingsource ↗
- 2025-03-18ECGiulia Del Brenna · Head of UnitMenarini, a €3 billion revenue pharmaceutical manufacturer, mostly active in the generic medicines domain, wanted to discuss the recently adopted Commission proposal for a Critical Medicines Act (CMA), and provide some first reactions.source ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has A. Menarini Industrie Farmaceutiche Riunite s.r.l. disclosed?
A. Menarini Industrie Farmaceutiche Riunite s.r.l. (EU Transparency Register no. 138719717404-80) appears in 38 disclosed meetings with EU officials and MEPs between 2025-03-18 and 2026-06-03: 5 with the European Commission and 33 with Members of the European Parliament.
What does A. Menarini Industrie Farmaceutiche Riunite s.r.l. lobby on?
A. Menarini Industrie Farmaceutiche Riunite s.r.l.'s disclosed EU meetings most often concern Health, Technology. Every meeting and its topic is listed with its official source on this page.
Who does A. Menarini Industrie Farmaceutiche Riunite s.r.l. meet in Brussels?
Across its disclosed meetings, A. Menarini Industrie Farmaceutiche Riunite s.r.l. has met Commission officials including Olivér Várhelyi, Maurice Whelan, Tobias Wiesenthal, and MEPs including MORETTI Alessandra, WÖLKEN Tiemo, FIOCCHI Pietro. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 138719717404-80) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.